SUSAN CLOUGH: Open Payments
NPI 1205664794 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,465 in 39 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $2,465
Food & beverage: $1,410Travel & lodging: $1,055
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 14 | $1,723 |
| Edwards Lifesciences Corporation | 1 | $161 |
| AstraZeneca Pharmaceuticals LP | 3 | $128 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| BridgeBio Pharma, Inc. | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $36 |
| ABIOMED | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: LINQ II, SAPIEN 3 Ultra RESILIA, ELIQUIS, LOKELMA, LEQVIO, Kerendia, Attruby, WAINUA.
Industry payments across CO — which companies pay providers there.
